Richa Vartak

489 total citations
22 papers, 366 citations indexed

About

Richa Vartak is a scholar working on Molecular Biology, Infectious Diseases and Toxicology. According to data from OpenAlex, Richa Vartak has authored 22 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Infectious Diseases and 4 papers in Toxicology. Recurrent topics in Richa Vartak's work include Protein Degradation and Inhibitors (5 papers), Antifungal resistance and susceptibility (3 papers) and Peptidase Inhibition and Analysis (3 papers). Richa Vartak is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Antifungal resistance and susceptibility (3 papers) and Peptidase Inhibition and Analysis (3 papers). Richa Vartak collaborates with scholars based in United States, Egypt and Poland. Richa Vartak's co-authors include Ketan Patel, Aishwarya Saraswat, Manali Patki, Blasé Billack, Rehab Hegazy, Suyash M. Patil, Nitesh K. Kunda, Yige Fu, Yuqi Yang and Zhe‐Sheng Chen and has published in prestigious journals such as Journal of Controlled Release, Molecules and International Journal of Pharmaceutics.

In The Last Decade

Richa Vartak

21 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richa Vartak United States 11 170 81 76 55 42 22 366
Ibrahim M. Ibrahim Saudi Arabia 13 104 0.6× 26 0.3× 90 1.2× 47 0.9× 26 0.6× 25 413
Yonghua Liu China 15 190 1.1× 94 1.2× 34 0.4× 62 1.1× 25 0.6× 60 600
Davinder Singh India 13 175 1.0× 98 1.2× 95 1.3× 21 0.4× 63 1.5× 38 665
Rinku Baishya India 12 164 1.0× 49 0.6× 50 0.7× 26 0.5× 42 1.0× 31 412
Laboni Mondal India 11 161 0.9× 34 0.4× 61 0.8× 34 0.6× 47 1.1× 13 403
Catherine Piveteau France 12 220 1.3× 85 1.0× 45 0.6× 136 2.5× 32 0.8× 25 496
Anca Butucă Romania 10 167 1.0× 46 0.6× 44 0.6× 26 0.5× 20 0.5× 29 479
Gurleen Kaur India 12 193 1.1× 200 2.5× 30 0.4× 68 1.2× 77 1.8× 32 643
Kwame N. Atuah United Kingdom 6 131 0.8× 48 0.6× 158 2.1× 24 0.4× 123 2.9× 7 370

Countries citing papers authored by Richa Vartak

Since Specialization
Citations

This map shows the geographic impact of Richa Vartak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richa Vartak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richa Vartak more than expected).

Fields of papers citing papers by Richa Vartak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richa Vartak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richa Vartak. The network helps show where Richa Vartak may publish in the future.

Co-authorship network of co-authors of Richa Vartak

This figure shows the co-authorship network connecting the top 25 collaborators of Richa Vartak. A scholar is included among the top collaborators of Richa Vartak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richa Vartak. Richa Vartak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vartak, Richa & Ketan Patel. (2024). Targeted nanoliposomes of oncogenic protein degraders: Significant inhibition of tumor in lung-cancer bearing mice. Journal of Controlled Release. 376. 502–517. 6 indexed citations
2.
Hegazy, Rehab, et al.. (2024). Lenvatinib-valproic acid self nanoemulsifying preconcentrate for the treatment of liver cancer. Journal of Molecular Liquids. 398. 124263–124263. 1 indexed citations
3.
4.
Das, Atanu Kumar, et al.. (2023). Arginine-Coated Nanoglobules for the Nasal Delivery of Insulin. Pharmaceutics. 15(2). 353–353. 6 indexed citations
5.
Vartak, Richa, et al.. (2023). Nanoformulation of A Novel Potent Ebselen Analog for Treatment of Vulvovaginal Candidiasis. Nanomedicine. 18(18). 1195–1206.
6.
Palekar, Siddhant, et al.. (2023). Corroborating various material-sparing techniques with hot melt extrusion for the preparation of triclabendazole amorphous solid dispersions. International Journal of Pharmaceutics. 640. 122989–122989. 10 indexed citations
7.
Saraswat, Aishwarya, Richa Vartak, Rehab Hegazy, et al.. (2023). Oral lipid nanocomplex of BRD4 PROteolysis TArgeting Chimera and vemurafenib for drug-resistant malignant melanoma. Biomedicine & Pharmacotherapy. 168. 115754–115754. 20 indexed citations
8.
Vartak, Richa, et al.. (2023). Cetuximab-based PROteolysis targeting chimera for effectual downregulation of NSCLC with varied EGFR mutations. International Journal of Biological Macromolecules. 252. 126413–126413. 19 indexed citations
9.
Saraswat, Aishwarya, et al.. (2022). Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs). Drug Discovery Today. 28(1). 103387–103387. 51 indexed citations
10.
Vartak, Richa, Aishwarya Saraswat, Yuqi Yang, Zhe‐Sheng Chen, & Ketan Patel. (2022). Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera. Pharmaceutical Research. 39(11). 2745–2759. 28 indexed citations
11.
Vartak, Richa, Joseph Jablonski, Sonia Mediouni, et al.. (2022). Bictegravir nanomicelles and anionic pullulan loaded vaginal film: Dual mechanistic pre-exposure prophylaxis (PrEP) for HIV. International Journal of Biological Macromolecules. 221. 416–425. 5 indexed citations
12.
Saraswat, Aishwarya, Richa Vartak, Manali Patki, & Ketan Patel. (2021). Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir. Cannabis and Cannabinoid Research. 8(6). 1008–1018. 5 indexed citations
13.
Vartak, Richa, Suyash M. Patil, Aishwarya Saraswat, et al.. (2021). Aerosolized Nanoliposomal Carrier of Remdesivir: An Effective Alternative for COVID-19 Treatment In Vitro. Nanomedicine. 16(14). 1187–1202. 63 indexed citations
14.
Vartak, Richa, Ketan Patel, Antonio Di Stefano, et al.. (2021). Antifungal Activity of Novel Formulations Based on Terpenoid Prodrugs against C. albicans in a Mouse Model. Pharmaceutics. 13(5). 633–633. 11 indexed citations
15.
Vartak, Richa, et al.. (2021). Evaluation of the antifungal activity of an ebselen-loaded nanoemulsion in a mouse model of vulvovaginal candidiasis. Nanomedicine Nanotechnology Biology and Medicine. 37. 102428–102428. 15 indexed citations
16.
Vartak, Richa, Manali Patki, Joseph Jablonski, et al.. (2020). β-cyclodextrin polymer/Soluplus® encapsulated Ebselen ternary complex (EβpolySol) as a potential therapy for vaginal candidiasis and pre-exposure prophylactic for HIV. International Journal of Pharmaceutics. 589. 119863–119863. 25 indexed citations
17.
Patki, Manali, Richa Vartak, Joseph Jablonski, et al.. (2020). Efavirenz nanomicelles loaded vaginal film (EZ film) for preexposure prophylaxis (PrEP) of HIV. Colloids and Surfaces B Biointerfaces. 194. 111174–111174. 15 indexed citations
18.
Patki, Manali, Siddhant Palekar, Pavan Kumar Nukala, Richa Vartak, & Ketan Patel. (2020). Overdose and Alcohol Sensitive Immediate Release System (OASIS) for Deterring Accidental Overdose or Abuse of Drugs. AAPS PharmSciTech. 22(1). 9–9. 8 indexed citations
19.
Vartak, Richa, et al.. (2020). Ebselen nanoemulgel for the treatment of topical fungal infection. European Journal of Pharmaceutical Sciences. 148. 105323–105323. 58 indexed citations
20.
Palekar, Siddhant, Pavan Kumar Nukala, Richa Vartak, & Ketan Patel. (2020). Abuse deterrent immediate release film technology (ADRIFT): A novel bilayer film technology for limiting intentional drug abuse. International Journal of Pharmaceutics. 590. 119944–119944. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ibrahim M. Ibrahim Breakdown of academic impact, for papers by Yonghua Liu Breakdown of academic impact, for papers by Davinder Singh Breakdown of academic impact, for papers by Rinku Baishya Breakdown of academic impact, for papers by Laboni Mondal Breakdown of academic impact, for papers by Catherine Piveteau Breakdown of academic impact, for papers by Anca Butucă Breakdown of academic impact, for papers by Gurleen Kaur Breakdown of academic impact, for papers by Kwame N. Atuah
Rankless by CCL
2026